Biblio

Author [ Title(Desc)] Type Year
Filters: Author is Zhang, Wei  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Sui Y, Zhu R, Hu W, Zhang W, Zhu H, Gong M, Gao L, Cao T, Tang T, Yu B, et al. Phage display screening identifies a prostate specific antigen (PSA) prostate cancer cell specific peptide to retard castration resistance of prostate cancer. Transl Oncol. 2021;14(3):101020.
Komatsu M, Wheeler HE, Chung S, Low S-K, Wing C, Delaney SM, Gorsic LK, Takahashi A, Kubo M, Kroetz D, et al. Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy. Clin Cancer Res. 2015.
Wang J, Yu H, Ma Q, Zeng P, Wu D, Hou Y, Liu X, Jia L, Sun J, Chen Y, et al. Phase separation of OCT4 controls TAD reorganization to promote cell fate transitions. Cell Stem Cell. 2021.
Huang T, Yang Y, Song X, Wan X, Wu B, Sastry N, Horbinski CM, Zeng C, Tiek D, Goenka A, et al. PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells. Mol Cell. 2021.
Ma J, Feng B, Kong D, He J, Guo R, Amponsah AErnest, Zhang W, Zhang S, Lv F, Song Y, et al. Production and validation of human induced pluripotent stem cell line from sporadic amyotrophic lateral sclerosis (SALS). Stem Cell Res. 2020;44:101760.
Uhlmann C, Nickel A-C, Picard D, Rossi A, Li G, Hildebrandt B, Brockerhoff G, Bendt F, Hübenthal U, Hewera M, et al. Progenitor cells derived from gene-engineered human induced pluripotent stem cells as synthetic cancer cell alternatives for in vitro pharmacology. Biotechnol J. 2022:e2100693.
Niu X, Zhao Y, Yang N, Zhao X, Zhang W, Bai X, Li A, Yang W, Lu L. Proteasome Activation by Insulin-like Growth Factor-1/Nuclear Factor Erythroid 2-related Factor 2 Signaling Promotes Exercise-induced Neurogenesis. Stem Cells. 2019.
Pan C, Zhai Y, Wang C, Liao Z, Wang D, Yu M, Wu F, Yin Y, Shi Z, Li G, et al. PVR Receptor-Based CAR-T Cells Combined with NK-92 Cells Exert Potent Activity Against Glioblastoma. J Natl Cancer Inst. 2023.
R
Derman BA, Jasielec J, Langerman SS, Zhang W, Jakubowiak AJ, Chiu BC-H. Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis. Blood Cancer J. 2020;10(8):80.
Long J, Yao Z, Zhang W, Liu B, Chen K, Li L, Teng B, Du X-F, Li C, Yu X-F, et al. Regulation of Osteoimmune Microenvironment and Osteogenesis by 3D-Printed PLAG/black Phosphorus Scaffolds for Bone Regeneration. Adv Sci (Weinh). 2023:e2302539.
Zhang W, Qian S, Tang B, Kang P, Zhang H, Shi C. Resveratrol inhibits ferroptosis and decelerates heart failure progression via Sirt1/p53 pathway activation. J Cell Mol Med. 2023.
Song X, Tiek D, Miki S, Huang T, Lu M, Goenka A, Iglesia RP, Yu X, Wu R, Walker MN, et al. RNA splicing analysis deciphers developmental hierarchies and reveals therapeutic targets in adult glioma. J Clin Invest. 2024.
Luo L, Zhang W, You S, Cui X, Tu H, Yi Q, Wu J, Liu O. The role of epithelial cells in fibrosis: mechanisms and treatment. Pharmacol Res. 2024:107144.
Cai R, Wang L, Zhang W, Liu B, Wu Y, Pang J, Ma C. The role of extracellular vesicles in periodontitis: pathogenesis, diagnosis, and therapy. Front Immunol. 2023;14:1151322.
Su S, Chen Y, Zhang P, Ma R, Zhang W, Liu J, Li T, Niu H, Cao Y, Hu B, et al. The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022. Eur J Med Chem. 2022;243:114680.

Pages